Metastatic Gastric Cancers Recruiting Phase 2 Trials for Docetaxel (DB01248)

Also known as: Metastatic Gastric Cancer / Gastric cancer stage IV NOS / Gastric cancer stage IV / Malignant neoplasm of stomach stage IV NOS / Gastric malignancy stage IV NOS / Stomach cancer stage IV NOS

IndicationStatusPhase
DBCOND0063580 (Metastatic Gastric Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03154983The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric CancerTreatment